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Abstract
Background: Cellular response to external stimuli requires propagation of corresponding signals
through molecular signaling pathways. However, signaling pathways are not isolated information
highways, but rather interact in a number of ways forming sophisticated signaling networks. Since
defects in signaling pathways are associated with many serious diseases, understanding of the
crosstalk between them is fundamental for designing molecularly targeted therapy. Unfortunately,
we still lack technology that would allow high throughput detailed measurement of activity of
individual signaling molecules and their interactions. This necessitates developing methods to
prioritize selection of the molecules such that measuring their activity would be most informative
for understanding the crosstalk. Furthermore, absence of the reaction coefficients necessary for
detailed modeling of signal propagation raises the question whether simple parameter-free models
could provide useful information about such pathways.
Results: We study the combined signaling network of three major pro-survival signaling pathways:
Epidermal Growth Factor Receptor (EGFR), Insulin-like Growth Factor-1 Receptor (IGF-1R),
and Insulin Receptor (IR). Our study involves static analysis and dynamic modeling of this network,
as well as an experimental verification of the model by measuring the response of selected signaling
molecules to differential stimulation of EGF, IGF and insulin receptors. We introduced two novel
measures of the importance of a node in the context of such crosstalk. Based on these measures
several molecules, namely Erk1/2, Akt1, Jnk, p70S6K, were selected for monitoring in the network
simulation and for experimental studies. Our simulation method relies on the Boolean network
model combined with stochastic propagation of the signal. Most (although not all) trends suggested
by the simulations have been confirmed by experiments.
Conclusion: The simple model implemented in this paper provides a valuable first step in modeling
signaling networks. However, to obtain a fully predictive model, a more detailed knowledge
regarding parameters of individual interactions might be necessary.
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Background
Signal transduction is the primary means by which cells
respond to external stimuli such as nutrients, hormones,
growth factors, and stress. Following the discovery of
reversible phosphorylation [1] which provides the funda-
mental mechanisms of signal propagation, a large spec-
trum of methods that cells adopt to propagate a signal has
been elucidated [2]. The discovery of basic principles of
modular organization on the level of signaling domains
[3] as well as on the level of whole signaling pathways (as
exemplified by the MAP Kinase cascade which is present
in multiple copies in eukaryotic organisms added to the
understanding of the signaling process. These increasingly
more accurate [2,4] descriptions of signaling mechanisms
are accompanied with the reconstruction of ever larger sig-
naling pathways and networks.
Defects in signaling pathways are associated with many
serious diseases, in particular cancer [5]. Extensive molec-
ular-level knowledge of signaling mechanisms raised
expectation that such defects can be corrected with a ther-
apeutic intervention using either receptor-specific anti-
bodies or low-molecular weight compounds interfering
with activation of the signaling molecules. However, indi-
vidual signaling pathways do not act in isolation, but
rather interact with each other, forming complex signaling
networks that respond to diverse, often contradictory,
stimuli. Such cross-talk can involve components that are
common between pathways, as well as positive and nega-
tive feedback loops [2]. Furthermore, response to a signal
depends on the activation threshold and signal duration
[6] adding yet another level of complexity to the system.
In consequence, a system level understanding of signaling
networks is lagging behind the molecular-level knowledge
of its constitutive components, which hinders a system-
atic approach to drug discovery.
The Epidermal Growth Factor (EGF) signaling pathway is
one of the best understood receptor signaling pathways
[7]. Members of the EGF receptor (EGFR) family have
been shown to be overexpressed in several types of cancers
and have been used as main targets for recently developed
molecular therapies [8]. However, a significant fraction of
cancers has been resistant to the current approach which
is based on blocking individual growth factor receptors
[9] suggesting that there may be crosstalk between EGF
and other pro-survival pathways.
The interplay between the EGF pathway (and EGF plus
Insulin) and its antagonist "pro-death" TNF signaling
pathway has recently been a focus of a number of compu-
tational and experimental studies [10-17].
This work focuses on the signaling network formed by the
interaction of three signaling pathways: Epidermal
Growth Factor Receptor (EGFR), Insulin-like Growth Fac-
tor 1 Receptor (IGF-1R), and Insulin Receptor (IR). All
three pathways are pro-survival and have been experimen-
tally linked to cancer. Therefore, it is imperative for the
development of successful targeted therapies aimed at
these pathways that the crosstalk between them is well
understood. In this work, we provide a combined compu-
tational and experimental analysis of this crosstalk.
The level of abstraction of a computational approach
depends on the prior knowledge of the system and the
type of experimental data [18]. We used a multi-level
approach. First, we used a high level network model to
discover basic properties of the network topology and to
identify the nodes of the network that are most likely
involved in the crosstalk. Next, we developed fuzzy
Boolean network model to predict activities of nodes as
functions of combinatorial stimulation of the EGF, IGF,
and insulin receptors. That is we assume that each edge
passes the signal with a certain probability. Consequently,
rather than having binary active/inactive values, each
node is active or not with a probability computed using a
simulation protocol. In each step of the simulation, the
probability of a node being active (i.e. activity level) is
computed based on the activity values of its neighbors
and the probabilities of transferring the signal along the
corresponding edges. In general, different edges can have
different probabilities (represented as edge weights);
however, in this study we assign them equal values. Note
that the method of signal propagation used in our
approach is different from Petri net, which has been pre-
viously used to analyze signaling pathways [19]. Unlike
Petri nets which require two types of nodes ("active" tran-
sitions and "passive" places), we use only one type of
node. Each node computes the probability of activation
using a Boolean function. In contrast, the transition nodes
in Petri nets operate by passing units of information (the
so called tokens).
The changes in activation of selected nodes following dif-
ferent levels of stimulation of these receptors were also
measured experimentally. The experimental results were
used to assess if the simple model was able to recover the
general trends in the dependence between combinatorial
stimulation and the level of activation and to further
adjust the parameters of the network.
For this study, EGF, IGF, and insulin pathway information
provided by STKE was combined into one signaling net-
work. Our results indicate that, despite its simplicity, the
model is able to predict several general patterns of the
response and thus is expected to provide a good starting
point for investigating signaling networks. To obtain a
fully predictive model, a more accurate parameterization
is necessary either by acquiring the precise knowledge ofBMC Systems Biology 2009, 3:88 http://www.biomedcentral.com/1752-0509/3/88
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kinetic parameters of individual interactions or, given a
sufficient number of experimental measurements, by
training the model to fit the data.
Results and discussion
Network building and its static analysis
We started by combining the information on EGF, IGF,
and insulin pathways provided by STKE into one signal-
ing network [20-22]. The resulting network comprises of
82 nodes representing receptor, cytosolic and nuclear pro-
teins connected by stimulatory and inhibitory edges Fig-
ure 1. In this network, IGF-1R signaling was mediated
only by β-arrestin. Therefore, to better reflect existing
knowledge about this pathway in our network, we added
three edges connecting IGF-1R to its well described adap-
tor proteins: IRS, IRS2 and Shc [23] (Figure 1).
In order to analyze the crosstalk between the three signal-
ing pathways we experimentally monitored the activity of
selected signaling molecules as a function of different
activity levels of the three receptors. Monitoring of the
activity of all molecules in the network would be most
Network used for static and dynamic analysis of combined EGFR, IGF-1R and IR signaling Figure 1
Network used for static and dynamic analysis of combined EGFR, IGF-1R and IR signaling. Figure drawn using 
Cytoscape [35]BMC Systems Biology 2009, 3:88 http://www.biomedcentral.com/1752-0509/3/88
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informative but, unfortunately, this is not feasible with
current technology. This necessitated the development of
a method for selection of the most informative set of mol-
ecules. An analysis of the topological properties of a bio-
logical network provides a good first view of the network
as a whole and helps to identify components that play a
central role in signal propagation. In the context of bio-
logical networks, two such measures attracted particular
attention: the degree of the node and the betweenness
centrality [24-26]. The degree of a node is the number of
edges adjacent to the node, which is the number of inter-
acting partners. The betweenness centrality is the sum
over all pairs of nodes of the fraction of the shortest paths
that go through a given node. Unfortunately, none of the
above measures are directed towards identifying mole-
cules most likely to be affected by the crosstalk between
two or more sub-networks, thus they cannot be used to
prioritize selection of the molecules such that measuring
their activity would be most informative for understand-
ing the crosstalk. Therefore, in this work we introduce two
new measurements: network crosstalk and path crosstalk.
The network crosstalk of a node is the difference in the
degree of the node in the network containing all consid-
ered pathways and the maximum degree of this node in
any one individual pathway. A high network crosstalk value
implies that a node is a branching node connecting two or
more pathways.
To define the second measure, path crosstalk, we first intro-
duce the signal-flow centrality. This measure considers the
shortest paths going from all receptor molecules to all
path-ending nuclear molecules. For each node, its signal-
flow centrality equals the number of such paths going
through it. We define the path crosstalk of a node as the dif-
ference between its signal-flow centrality for the entire
network and its maximum signal-flow centrality in any
one individual pathway. A high path crosstalk value sug-
gests that a node is more important in the combined net-
work than it was in the individual pathways. The network
crosstalk and path crosstalk values for the signaling mole-
cules which have non-zero network crosstalk are given in
Figure 2.
The nodes with high network crosstalk correspond to the
nodes where the signals from the diverse corresponding
starting points are merged together while the nodes with
high path crosstalk correspond to signaling molecules
that are branching points for several pathways. We
observed that the nodes indentified by this method as
important for intra-pathway communication correspond
to molecules that are assumed to be major crosstalk play-
ers in these well studied pathways. Most of these mole-
cules are indicated as important in tumor genesis as well
as other pathological states. This suggests that this
approach provides a reasonable way of prioritizing exper-
imental measurements for studies of a crosstalk between
pathways and shall be useful for studies of less under-
stood pathways.
Computational analysis of networks response to 
differential receptors stimulation
To analyze the activity of the network in response to vari-
ous levels of stimulation of the three receptors, we intro-
duced a simple computational model. Similar to the
standard representation of signaling pathways, the net-
work is represented as a directed graph with two types of
edges: activation edges and inhibition edges. However,
the nodes as well as the edges have weights. This modifi-
cation allows to replace the standard Boolean logic model
[27] with fuzzy logic - a generalization of the standard
Boolean logic that handles the concept of partial truth.
Using such generalization is justified by the fact that the
nodes in a signaling network typically represent assem-
blies of individual molecules each of which could be
active or not. Consequently, each node is associated with
a weight between 0 and 1 reflecting the level of activation
of a given molecule (percentage of active molecules). In
an iterative procedure (see Methods section) the activity
of each node is updated based on the activities of its
neighbors. In contrast to the node weights, the edge
weights are not computed but included as a part of the
input. The weight of an edge is a value between 0 and 1
representing the probability (efficiency) with which the
signal is propagated along this edge. The necessity for
modeling such signal loss was discovered by the compar-
ison of the simulation results with edge weights set to one
with the experimental results (data not shown). The
trends observed for edge weights less than 1.0 had a much
better agreement with the experimental results. Conse-
The network crosstalk and path crosstalk values for all the  signaling molecules in the network which have non zero net- work crosstalk value Figure 2
The network crosstalk and path crosstalk values for 
all the signaling molecules in the network which have 
non zero network crosstalk value.
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quently, we used 0.8 as the default setting for all edge
weights. In the next section we show the results for two
different setting of weights. Obviously it is possible, and
desirable if supported by a sufficient amount of experi-
mental data, to assign different weights to different edges.
However, to avoid any over-fitting in our simulation, we
assigned non-default weights only to a small number of
edges where such modification could be justified based
on literature. We describe these modifications in the
experimental validation section.
The default initial setting of all nodes is zero with the
exception of the values for the receptors: EGF Receptor
(EGFR), IGF Receptor (IGF-1R), and Insulin Receptor
(IR). In the simulation we used five different levels of acti-
vation of these receptors: 0%, 25%, 50%, 75%, and 100%.
Every possible combination of activation levels was simu-
lated resulting in 125 different settings of the input
parameters. The results of the simulation for the four mol-
ecules selected for experimental measurements: Erk1/2,
Akt1, Jnk, and p70S6K, are given in Figure 3. As illustrated
in Figure 2 all of them have "non zero" network crosstalk.
Moreover, ERK1/2 and pJNK has also high path crosstalk
value. All chosen molecules are downstream kinases, acti-
vated through phosphorylation, and influencing cell fate
through modification of transcription and translation fac-
tors or direct phosphorylation of survival/apoptotic path-
ways components.
The results for the remaining molecules with non-zero
network crosstalk are given in Additional file 1: Figure S1.
The results of dynamic simulations for the four monitored molecules Figure 3
The results of dynamic simulations for the four monitored molecules. Each layer on the graph is a different level of 
activation of IGF-1R, with top layers corresponding to higher IGF-1R activities. Signal propagation for all edges was set at 0.8, 
except for the edges IGF-1R-Shc, IR-Shc, IRS-Shc and IGF-1R-β-arrestin whose weights were set as close to zero.BMC Systems Biology 2009, 3:88 http://www.biomedcentral.com/1752-0509/3/88
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In computational simulation, all selected molecules
showed dynamic dependency on the activation levels of at
least two receptors. This was also true for all other mole-
cules with non-zero network crosstalk (data not shown)
as it would be expected based on the definition of network
crosstalk. For Jnk, the dependence on EGFR activation is
not very strong except near the point (0,0,0) while the
activity of P70S6K is relatively stable for all three parame-
ters (again, except near the point (0,0,0)). For Erk1/2 the
strongest influence results from the variability in EGFR
activation, while for Akt1 the variability in the activation
of any of EGFR or IR has a similar effect which is also quite
similar to the effect of IGF-1R.
As demonstrated in Figure 3, ERK1/2 activity was pre-
dicted not to depend on IR stimulation (Figure 3A), while
EGFR activation was predicted to lead to activation of
ERKs. The effect was even more pronounced when the cell
was co-stimulated with IGF-1R. However, IGF-1R activa-
tion alone was predicted not to contribute to ERK1/2
activity as shown in Figure 3A.
Activation of the other MAPK family kinase JNK was pre-
dicted to depend strongly on all three receptors tested.
According to simulation, the maximum activation level is
observed after saturation of all receptors. EGFR was pre-
dicted to have the lowest impact. IR and IGF-1R applied
alone at the same conditions activated JNK (Figure 3B).
Simulations of AKT kinase suggested that its activation
depends on all tested receptors. Remarkably, efficient acti-
vation is achieved by stimulation and co-stimulation of IR
and IGF-1R, while saturation of EGFR alone results in AKT
activation at a lower extent. However, while activity of
AKT increases rapidly with activation of either IGF-1R or
EGFR and achieves levels close to the maximal, the satura-
tion of both IGF-1R and EGFR seems necessary to main-
tain the highest AKT activation level. Under these
conditions, IR seems to have the lowest impact (Figure
3C).
Our simulations also suggested a strong response of
P70S6K to the activation of the three tested receptors.
Even low activation of EGFR, IGF-1R and IR saturates
p70S6K activity and further stimulation of receptors has a
minimal effect of p70S6K activation (Figure 3D).
As discussed in the next section most (but not all) of these
trends were confirmed experimentally.
Experimental validation
Four proteins with non-zero network crosstalk, Erk1/2,
Akt1, P70S6K and Jnk, were selected for experimental val-
idation of our simple model and to obtain a set of quan-
titative data to guide necessary adjustments of the model.
All molecules are indicated as important in tumorigenesis
as well as other pathological states e.g. diabetes. All of
them are well studied and tools for measuring their acti-
vation are readily available.
For the experimental study we used SKOV3 cell line.
Receptor expression analysis of SKOV3 cells confirmed
expression of EGFR, IGF-1R, and IR (data not shown). In
order to compare experimental results with our computa-
tional results, we next measured the saturation levels of
receptors in response to incubation with EGF, IGF and Ins
(Additional file 1: Table S1). We also measured the cross-
stimulation of IGF-1R and IR by their ligands, so that the
corresponding correction could be included into simula-
tion (Additional file 1: Table S1). This set of experiments
allowed us to translate ligand dosage into activation level.
Five sets of experiments were performed step-wise increas-
ing the receptors activation by 25%. Using Mesoscale Dis-
covery platform plates we measured the response to
activation of individual receptors (Additional file 2: Table
S1) and their co-stimulation in combination with each
other (Additional file 2: Table S3). The results were
reported as the percentage of phosphorylation of each
examined molecule.
We observed that computer simulations were able to reca-
pitulate most of trends observed in the experimental stud-
ies. In particular, increasing Akt1 activity in response to
receptor stimulation was confirmed for all tested combi-
nations. The highest Akt1 activation level was observed
when cells were co-stimulated with all three ligands
simultaneously (Additional file 2: S3). As predicted,
increased EGFR stimulation translated to increased Erk1/
2 activity. However co-stimulation of the receptors with
insulin and/or IGF did not lead to increase in Erk1/2 activ-
ity. Specifically, we didn't observe a dependency of the
activity of Erk1/2 on activation level of IR and IGF-1R.
This was not in the agreement with our initial model
derived directly from the STKE data. However, this coun-
terintuitive observation could be explained in light of the
findings reported by Yuhong Lu et al. 2003 [28] The
authors showed that in breast cancer cells with high levels
of HER2 expression, signaling from IGF to Erk1/2 was
attenuated, and this inhibition was reversed after the
number of HER2 had been lowered by treatment with
shRNA. They also showed that the overexpression of
HER2 increased the baseline level of Shc phosphorylation
and the association of Shc with Grb2, but reduced the IGF
induced Shc phosphorylation, the IGF induced Shc asso-
ciation with Grb2, and consequently the Erk1/2 activa-
tion. They formulated the hypothesis that induction of
Shc phosphorylation and its association with Grb2 by
HER2 overexpression might result in a reduction of free
Shc and Grb2 available upon IGF-1R activation in these
cells. Since SKOV3 cells express high level of HER2, weBMC Systems Biology 2009, 3:88 http://www.biomedcentral.com/1752-0509/3/88
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tried to apply the same explanation to address observed
discrepancies. To reflect this situation in our model, we
reduced the weights of the IR-Shc, Irs-Grb2, and IGF-1R -
Shc edges. This modification resulted in a significant
decrease in Erk1/2 sensitivity to Ins stimulation and a bet-
ter fit to the experimental data (Figure 3, Additional file 2:
Table S3). However, this modification did not change the
Erk1/2 response to IGF (data not shown). To elucidate the
reasons for the above inconsistency, we repeated the com-
putational signal flow analysis and we found out that the
only node able to mediate the signal flow from IGF-1R to
Erk1/2 is β-arrestin. This pathway was reported by Lefko-
vitz's group in 2003 and has been included in Science Sig-
naling [29]. The authors showed that IGF-bound
receptors can signal through β-arrestin in a kinase inde-
pendent manner resulting in Erk1/2 activation in
melanoma cells [30] and Akt1 in mouse embryo fibrob-
last (MEF) [31]. It appears, however, that in SKOV3 cells,
at least in our experimental setting, β-arrestin does not
play the crucial role in signal transduction from EGFR to
Erk1/2. Therefore, in order to better fit the experimental
data, we decreased the probability of the IGF-1R-β-arres-
tin edge. This resulted in a reduced response of Erk1/2 to
IGF stimulation (Figure 4.B1).
Figure 4 shows all experimental measurements alongside
with simulation results after the modifications for Akt1
and Erk1/2 as described above. The computational results
are shown for two parameter setting of all remaining
edges: (i) all edges not discussed above are set to 0.8, (ii)
all activation edges set as in (i), while all inhibition edges
set to 0.5. It is clear that, while the slopes of the regression
lines are different in both setting of the parameters, the
general trend remains the same. Table Additional file 1:
Table S1 and Additional file 2: Table S3 provides full list
the results of experimental and computational analysis for
the first parameter setting.
However, a few discrepancies remained unresolved. For
example, while in agreement with simulation results,
experimental data showed weak increase in p70S6K activ-
ity after stimulation with EGF, no such simulation-pre-
dicted increase was obtained experimentally for Ins and
IGF. It appears that, in SKOV3 cells, the p70S6K activation
is affected only by EGF. Similar inconsistency is observed
for Jnk. Interestingly, despite the fact that it is well estab-
lished that Jnk kinase mainly responds to stress stimuli
and inflammatory cytokines, there are reports pointing
out induction of Jnk activity after stimulation with growth
factors [32,33]. Such trends are also predicted by our com-
putational model. However, in our experiments, stimula-
tion with different combination of growth factors did not
cause increase in T183 and Y185 phosphorylation of Jnk
(Additional file 2: Table S2). Again, it is possible that sig-
nificant overexpression of HER2 causes perturbation in
the Jnk activation pathway in a way that is not captured by
our model. Additional studies are required in order to
resolve these discrepancies.
Conclusion
It is now understood that traditionally defined singling
pathways are not functioning in isolation but rather form
whole signaling networks involving crosstalk between
individual pathways. Can such crosstalk be studied in the
absence of high throughput technology that would allow
measuring reaction rates, association constants, and other
parameters needed to faithfully model a signaling net-
work? We addressed this question on two levels. First,
given that we deal with low throughput, labor intensive
technologies, we needed to have a measure that would
prioritize experimental measurements. To achieve this
goal, we developed two measures of involvement of a
node in a crosstalk. These measures are based on static,
topological properties of the network and are intuitive
extensions of centrality measures used to asses essentiality
of proteins in protein-protein interaction networks. Sub-
sequently, we used so defined crosstalk measures to facil-
itate the selection of relevant molecules for computational
and experimental evaluation.
The second question that we addressed in this work was
whether a simple model that lacks specific data such as
abovementioned reaction rates, association constants, etc.
can predict activity of a network in response to various lev-
els of stimuli. Consequently, we developed a simple
model and tested it on the network constructed by com-
bining EGF, IGF and insulin signaling pathways. Despite
its simplicity, the model was in agreement with most
experimentally observed trends. It proved to be a valuable
tool in the initial investigation of the signaling network in
SKOV3 cells. Specifically, the examination of the discrep-
ancy between the expected and obtained results pointed
to possible differences between signaling in the studied
SKOV3 cells and the available canonical signaling path-
ways. We confirmed some of these discrepancies through
a literature search and subsequently corrected the model.
Intuitively, one can see our model as a simple extension
of the standard Boolean-network type of model by adding
a stochastic component to it. This view is intuitive but it
has not been, until now, confronted with reality. Interest-
ingly, we found that a necessary element of the model is
the assumption that the signal is not propagated with
100% efficiency. Without this assumption, the model was
unable to correctly predict most of the trends.
Our study indicate, that while crude models, such as the
one exercised in this paper, cannot substitute for more
precise simulation, they can still provide valuable infor-
mation on the response of signaling network to stimuli.BMC Systems Biology 2009, 3:88 http://www.biomedcentral.com/1752-0509/3/88
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Comparison between experimental and simulated data Figure 4
Comparison between experimental and simulated data. In the figures in the left column, y axes are activities of Erk1/2; 
In the figures in the right column, y axes are activities of Akt1. In each figure, blue diamonds represent real data; green triangles 
represent the results of simulation, where we set weights of both activation and blockage edges to 0.8; red squares represent 
the data of simulation, where we set weights of activation edges to 0.8 and blockage edges to 0.5. The caption above each fig-
ure indicates the x and y variables. Figures of D and E report the results for the 100% stimulation of remaining receptors. In 
simulation, we also included a correction for the cross-stimulation between IR and IGF-1R, according to Table S1.BMC Systems Biology 2009, 3:88 http://www.biomedcentral.com/1752-0509/3/88
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As more experimental data is being gathered, the parame-
ters of the models will be adjusted to fit the data. It is also
possible (and quite likely) that our network is incomplete.
However given more data points one can start to employ
Bayesian methods to fill the missing edges and improve
this aspect of the model.
Methods
Experimental procedures
Human ovary carcinoma, SKOV3, cells were cultured in
McCoy medium supplemented with FBS to the final con-
centration of 10% at 37°C in 5% CO2. For every experi-
ment, five 10 cm Petrie Dishes were plated with 2 × 106
cells each to obtain 90% of confluence fifteen hours later.
Cells were then starved for 24 hours in McCoy with 0.5%
FBS and subsequently stimulated with different combina-
tion of EGF, IGF and Ins for 15 min. After the 15-min
stimulation the cells were immediately rinsed two times
with ice-cold PBS and lysed in complete Mesoscale Dis-
covery (MSD) lyses buffer containing complete mix of
proteases and phosphatases inhibitors. After 20 min of
incubation cells were sonicated in four 10-second inter-
vals, followed by a cooling step. Finally, the cell lysates
were centrifuged at 15000 G for 20 min, aliquoted in
small volumes, flash frozen, and stored at -80°C for fur-
ther analyses. Protein phosphorylation levels were meas-
ured using signaling MAPK and Akt1 panel phospho/total
assay. EGFR saturation level was determined using EGFR
activated/total duplex kit. Saturation of IR and IGF-1R was
measured using Insulin signaling phospho/total assay. All
assays were purchased from Mesoscale Discovery plat-
form; Gaithersburg, MD and the measurements were car-
ried out according to manufacturer protocols. Each
measurement was performed in triplicates. Protein phos-
phorylation was calculated as the ratio of signal of "phos-
phorylated" form to it's "total" counterpart" multiplied by
factor 100.
Computational procedures
The network simulation was performed by iteratively tra-
versing the nodes of the network using a Breadth First
Search (BFS) approach [34]. Each BFS traversal started
from the receptors and propagated the signal towards the
terminal nodes. The activity of each node is determined
from the activities of its neighbors in the previous step as
described below. The initial values of the activities of all
nodes were set to zero with the exception of the receptor
activities where every possible combination of each level
of activation (0%, 25%, 50%, 75%, and 100%) was used
and kept constant during the simulation. Since in this
computation we are interested in estimating the steady
state activation levels of these molecules in response to
various activation levels, the fact that we used BFS order
was not critical (although it is useful for applications of
our software to model response to a short impulse rather
than prolonged stimulation). Let u  be the node to be
updated and let At(i) denote the activity of node i as com-
puted in the t-th iteration and let w(i, j) be the weight of
edge (i, j). Let S be the set of neighbors of u that are acti-
vators and B be the set of repressors. Informally we com-
pute the probability of node u being activated by at least
one activator ("or" function on activators) and not being
repressed by any of the repressors ("and" function on
repressors). By De Morgan's laws, At(u) is computed as
follows:
For comparison with experiments we used averaged
results of 100 iterations.
The simulation program is currently available on request
and a version with enhanced functionality, graphical dis-
plays, and appropriate graphical user interface will be
shortly publically available as a Cytoscape plugin [35].
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